Meeting
2014 ASCO Annual Meeting
Defining the neuroendocrine tumors landscape: A 15-year population-based analysis of incidence, outcomes, and therapies.
Authors
Julie I. Hallet
Odette Cancer Centre, Sunnybrook Health Sciences Centre; University of Toronto, Toronto, ON, Canada
Julie I. Hallet , Calvin Law , Ning Liu , Refik Saskin , Simron Singh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Neuroendocrine/Carcinoid
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4114)
DOI
10.1200/jco.2014.32.15_suppl.4114
Abstract #
4114
Poster Bd #
201
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
A natural history of gastroenteropancreatic neuroendocrine tumors evaluated at a tertiary cancer center: An observational study of 2,067 cases.
First Author: Benjamin Daniel Powers
Poster
2021 Gastrointestinal Cancers Symposium
Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
First Author: Estephany Abou Jokh Casas
Poster
2020 Gastrointestinal Cancers Symposium
Incidence and survival patterns of pancreatic neuroendocrine tumors over the last two decades: A SEER database analysis.
First Author: Mohamad Bassam Sonbol
Poster
2019 Gastrointestinal Cancers Symposium
Resection of primary tumor in liver only metastatic midgut neuroendocrine tumors.
First Author: Nicholas Manguso